Literature DB >> 1552427

Primary endodermal sinus (yolk sac) tumor of the falciform ligament.

J B Atkinson1, C E Foster, K P Lally, H Isaacs, S E Siegel.   

Abstract

Extragonadal yolk sac tumors (YSTs) are uncommon and YSTs of the liver are exceedingly rare, with only three reported cases in the literature. A case is described of primary YST of the falciform ligament extending into the left lobe of the liver in a 14-month-old boy. This is the first reported case of primary YST arising within the falciform ligament. The patient underwent an exploratory laparotomy after presenting with hemoperitoneum. An extremely friable and necrotic tumor was found extending from the falciform ligament into the liver. The tumor was debulked and the patient received 5 months of chemotherapy employing a modified Einhorn regimen. After a partial response to chemotherapy the patient had a second-look laparotomy, at which time a left hepatic lobectomy and en bloc resection of the falciform ligament was performed in order to remove residual tumor. At the present time the patient has no signs of metastases and is alive and well 2 years after his presentation.

Entities:  

Mesh:

Year:  1992        PMID: 1552427     DOI: 10.1016/0022-3468(92)90120-v

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  3 in total

1.  Solitary fibrous tumour of the falciform ligament containing multiple foci of malignant transformation.

Authors:  A L Gidwani; F J Mullan; B Kenny
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

Review 2.  Four "fine" messages from four kinds of "fine" forgotten ligaments of the anterior abdominal wall: have you heard their voices?

Authors:  Toshihide Yamaoka; Kensuke Kurihara; Aki Kido; Kaori Togashi
Journal:  Jpn J Radiol       Date:  2019-09-14       Impact factor: 2.374

3.  Malignant mesothelioma originating in the hepatic falciform ligament: report of a case.

Authors:  S Marubayashi; H Ohdan; T Asahara; M Ikeda; T Hinoi; K Fukuma; T Maeda; Y Oshiro; F Shimamoto; K Dohi
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.